Purdue Pharma L.P. company information, Employees & Contact Information

Purdue Pharma Plan of Reorganization Receives Overwhelming Creditor Support citybiz

Medicines From Purdue purduepharma.com

R.I. to receive nearly $30M in Purdue Pharma opioid settlement Rhode Island Current

What We Offer You purduepharma.com

Purdue Pharma L.P. Announces the Appointment of Alan W. Dunton, M.D. to Senior Vice President of Research & Development PR Newswire

UNMC, Purdue Pharma enter partnership to advance new drug development University of Nebraska Medical Center

Purdue Pharma offers $10-12 billion to settle opioid claims NBC News

The opioid crisis isn’t just the Sacklers’ fault – and making Purdue Pharma pay isn’t enough on its own to fix the pharmaceutical industry’s deeper problems The Conversation

Ryzolt now available for pain treatment McKnight's Long-Term Care News

15 States Reach a Deal With Purdue Pharma, Advancing a $4.5 Billion Opioids Settlement (Published 2021) The New York Times

OxyContin maker Purdue Pharma guilty plea latest development in DOJ's effort to hold drugmakers accountable for opioid epidemic CBS News

US Supreme Court halts Purdue Pharma bankruptcy settlement pending review Reuters

Behavioral Health Urgent Care Clinic: Providing Critical Care When and How It’s Needed purduepharma.com

Purdue Pharma Announces Patent Agreement with Egalet and Acura PR Newswire

Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal (Published 2019) The New York Times

Purdue Pharma L.P. Launches TeamAgainstOpioidAbuse.com PR Newswire

Purdue Pharma L.P. Announces Acquisition of TrkA Program from VM Pharma LLC PR Newswire

Mundipharma and Purdue Pharma Expand Pain Pipeline with New Deal for First-in-Class Sigma-1 Antagonist (S1A or MR309/E-52862) from ESTEVE PR Newswire

Purdue Pharma L.P. Receives FDA Approval for 7.5 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII PR Newswire

Purdue Pharma Agrees To $270 Million Opioid Settlement With Oklahoma NPR

Purdue Pharma Tentatively Settles Thousands of Opioid Cases (Published 2019) The New York Times

Purdue Pharma Reaches Tentative Deal To Settle Thousands Of Opioid Lawsuits NPR

The legal odyssey for OxyContin maker Purdue Pharma and its owners is complex. Here's what to know AP News

Purdue Pharma L.P. Receives FDA Approval for Hysingla™ ER (hydrocodone bitartrate) Extended-Release Tablets CII, A Once-Daily Opioid Analgesic Formulated with Abuse-Deterrent Properties PR Newswire

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma News-Medical

OxyContin maker to plead guilty to federal criminal charges, pay $8 billion, and will close the company CNN

Purdue Pharma to plead guilty in $8bn opioid settlement BBC

Supreme Court blocks opioid settlement with Purdue Pharma that shielded Sacklers NPR

Hysingla™ ER (hydrocodone bitartrate) Extended-Release Tablets CII Now Available PR Newswire

Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit (Published 2019) The New York Times

Purdue Pharma files for bankruptcy as part of a $10 billion agreement to settle opioid lawsuits CNN

Five more states sue OxyContin maker Purdue Pharma for opioid epidemic NBC News

Purdue Pharma filed for bankruptcy. What does it mean for lawsuits against the opioid manufacturer? statnews.com

Supreme Court wrestles with Purdue Pharma settlement and legal shield for Sackler family ABC News - Breaking News, Latest News and Videos

Purdue Pharma L.P. Re-launches Partners Against Pain Website PR Newswire

Additional strengths of OxyContin available Medical Professionals Reference

How Purdue Pharma's Sackler family hid their cash CBS News

Los Angeles Times Versus Purdue Pharma: Is 12-Hour Dosing of OxyContin Appropriate? MedCentral

Stein Sues Purdue Pharma Over Deceptive Marketing of Opioids North Carolina Health News

Purdue Pharma used deceptive sales tactic for OxyContin after settlement, ex-sales rep says CBS News

Prescription Addiction: Big Pharma and the Opioid Epidemic Drugwatch.com

Purdue Pharma, maker of OxyContin, backs off aggressive marketing amid lawsuits CBS News

Purdue Pharma, Sacklers reach new settlement agreement in opioid cases The Hill

In Guilty Plea, OxyContin Maker to Pay $600 Million (Published 2007) The New York Times